166 related articles for article (PubMed ID: 2836122)
1. Characterization of leukotriene B3: comparison of its biological activities with leukotriene B4 and leukotriene B5 in complement receptor enhancement, lysozyme release and chemotaxis of human neutrophils.
Lee TH; Sethi T; Crea AE; Peters W; Arm JP; Horton CE; Walport MJ; Spur BW
Clin Sci (Lond); 1988 May; 74(5):467-75. PubMed ID: 2836122
[TBL] [Abstract][Full Text] [Related]
2. Inhibition by leukotriene B5 of leukotriene B4-induced activation of human keratinocytes and neutrophils.
Kragballe K; Voorhees JJ; Goetzl EJ
J Invest Dermatol; 1987 May; 88(5):555-8. PubMed ID: 2437212
[TBL] [Abstract][Full Text] [Related]
3. Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene B5 and the double lipoxygenase product.
Lee TH; Menica-Huerta JM; Shih C; Corey EJ; Lewis RA; Austen KF
J Biol Chem; 1984 Feb; 259(4):2383-9. PubMed ID: 6321468
[TBL] [Abstract][Full Text] [Related]
4. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils.
Lee TH; Mencia-Huerta JM; Shih C; Corey EJ; Lewis RA; Austen KF
J Clin Invest; 1984 Dec; 74(6):1922-33. PubMed ID: 6096400
[TBL] [Abstract][Full Text] [Related]
5. Comparative effect of leukotriene B4 and leukotriene B5 on calcium mobilization in human neutrophils.
Seya A; Terano T; Tamura Y; Yoshida S
Prostaglandins Leukot Essent Fatty Acids; 1988 Oct; 34(1):47-50. PubMed ID: 2852812
[TBL] [Abstract][Full Text] [Related]
6. Biosynthesis and biological activity of leukotriene B5.
Terano T; Salmon JA; Moncada S
Prostaglandins; 1984 Feb; 27(2):217-32. PubMed ID: 6326200
[TBL] [Abstract][Full Text] [Related]
7. Synthetic leukotriene B4 is a potent chemotaxin but a weak secretagogue for human PMN.
Rollins TE; Zanolari B; Springer MS; Guindon Y; Zamboni R; Lau CK; Rokach J
Prostaglandins; 1983 Feb; 25(2):281-9. PubMed ID: 6304818
[TBL] [Abstract][Full Text] [Related]
8. Some newly synthesized leukotriene B4 analogs inhibit LTB4-induced lysozyme release from rat polymorphonuclear leukocytes.
Shimazaki T; Kobayashi Y; Sato F; Iwama T; Shikada K
Prostaglandins; 1990 Apr; 39(4):459-67. PubMed ID: 2160678
[TBL] [Abstract][Full Text] [Related]
9. Human neutrophil chemotactic and degranulating activities of leukotriene B5 (LTB5) derived from eicosapentaenoic acid.
Goldman DW; Pickett WC; Goetzl EJ
Biochem Biophys Res Commun; 1983 Nov; 117(1):282-8. PubMed ID: 6318749
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil chemotaxis to leukotriene B4 in vitro is decreased for the human neonate.
Dos Santos C; Davidson D
Pediatr Res; 1993 Mar; 33(3):242-6. PubMed ID: 8384710
[TBL] [Abstract][Full Text] [Related]
11. Dietary omega-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils.
Sperling RI; Benincaso AI; Knoell CT; Larkin JK; Austen KF; Robinson DR
J Clin Invest; 1993 Feb; 91(2):651-60. PubMed ID: 8381824
[TBL] [Abstract][Full Text] [Related]
12. Activation of neutrophil chemotaxis by leukotriene B4 and 5-hydroxyeicosatetraenoic acid in chronic inflammatory bowel disease.
Nielsen OH; Elmgreen J
Scand J Clin Lab Invest; 1987 Oct; 47(6):605-11. PubMed ID: 2823370
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the heterogeneous membrane potential response of neutrophils to N-formyl-methionyl-leucyl-phenylalanine (FMLP) by leukotriene B4: evidence for cell recruitment.
Fletcher MP
J Immunol; 1986 Jun; 136(11):4213-9. PubMed ID: 3009618
[TBL] [Abstract][Full Text] [Related]
14. Catabolism of leukotriene B5 in humans.
von Schacky C; Fahrer C; Fischer S
J Lipid Res; 1990 Oct; 31(10):1831-8. PubMed ID: 1964169
[TBL] [Abstract][Full Text] [Related]
15. 12(R)-methyl-leukotriene B3: a stable leukotriene B analogue toward the reductase metabolism.
Shimazaki T; Kawajiri K; Kobayashi Y; Sato F
Prostaglandins; 1993 Apr; 45(4):335-45. PubMed ID: 8388116
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effect between leukotriene B4 and leukotriene B5 on the induction of interleukin 1-like activity and calcium mobilizing activity in human blood monocytes.
Tatsuno I; Saito H; Chang KJ; Tamura Y; Yoshida S
Agents Actions; 1990 Mar; 29(3-4):324-7. PubMed ID: 2160190
[TBL] [Abstract][Full Text] [Related]
17. Effect of structural modification at carbon atom 1 of leukotriene B4 on the chemotactic and metabolic response of human neutrophils.
Clancy RM; Dahinden CA; Hugli TE
Anal Biochem; 1987 Mar; 161(2):550-8. PubMed ID: 3034102
[TBL] [Abstract][Full Text] [Related]
18. A reevaluation of the chemotactic potency of leukotriene B4 (LTB4).
Jubiz W
Biochem Biophys Res Commun; 1983 Feb; 110(3):842-50. PubMed ID: 6301465
[TBL] [Abstract][Full Text] [Related]
19. Chemotaxis of human neutrophils and eosinophils towards leukotriene B4 and its 20-w-oxidation products in vitro.
Czarnetzki BM; Rosenbach T
Prostaglandins; 1986 May; 31(5):851-8. PubMed ID: 3014612
[TBL] [Abstract][Full Text] [Related]
20. Effect of a leukotriene B4 receptor antagonist on leukotriene B4-induced neutrophil chemotaxis in cavine dermis.
Fretland DJ; Widomski DL; Zemaitis JM; Djurić SW; Shone RL
Inflammation; 1989 Oct; 13(5):601-5. PubMed ID: 2553605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
